AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05692388 — intervention group
Intervention type: OTHER
Intervention: Focus Groups and Intervention Mapping
Description: A subsample of patient interview/cross-sectional study participants will be invited back to participate in four focus groups (five participants/group) to review components of the intervention, give feedback on appropriateness, feasibility, acceptability, and likelihood of having an impact based on their lived experiences.
Study NCT04431830 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meaning-Centered Pain Coping Skills Training
Description: The goal of this intervention is to help participants manage pain so that they can engage with what gives them a sense of meaning, purpose, and significance in life.
Study NCT04546685 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Usual Care
Description: Participants who are randomized to the Usual Care group (waitlist for cross-over to ER) will be instructed to continue with their normal pain care. They will receive only study surveys (baseline, 2 weeks, and 1 month). Upon completion of the 1-month study, UC participants will be invited to cross-over and receive ER. Post-class treatment appraisal/satisfaction data only will be collected.
Study NCT04546685 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Empowered Relief
Description: The participants will attend an online Spanish Empowered Relief class. The two hour group session is delivered by a certified instructor and includes pain neuroscience education, 3 core pain management skills, experiential exercises, completion of a personalized plan for empowered relief. Participants download a Spanish binaural relaxation audio file for daily use.
Study NCT05086614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thymosin Alpha1
Description: Receive thymosin-alpha 1 1.6mg with subcutaneous injection, twice a week, for 6 months after radical resection.
Study NCT04195633 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic Hematopoietic Stem Cell Transplantation
Description: Undergo allogeneic hematopoietic stem cell transplantation
Study NCT04195633 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV
Study NCT03743194 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Exparel 266 MG Per 20 ML Injection
Description: The local anesthetic (LA) used for the PECS II or serratus plane blocks will be a 0.5% bupivacaine HCL, not to exceed 2.5mg/kg or up to 150mg. The LA solution can be diluted with preservative free normal saline for smaller patients to allow for appropriate volume of injection. Treatment patients will also be given liposomal bupivacaine (EXPAREL, Pacira Pharmaceuticals, Inc. San Diego, CA) in a dose of 266 mg in 20 ml can be safely combined with bupivacaine HCL at a ratio not exceeding 2:1, but cannot be combined with other local anesthetics due to the concern of rapid release of encapsulated bupivacaine and subsequent local anesthetic toxicity.
Study NCT03743194 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Patients randomized to standard analgesia technique will be given pain medications.
Study NCT03743194 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients randomized to standard analgesia technique will be given pain medications.
Study NCT05648734 — intervention group
Intervention type: DRUG
Intervention: Corticosteroids alone
Description: (≥ 20 mg prednisolone or its equivalent for ≥ 10 days after hospital discharge)
Study NCT05648734 — intervention group
Intervention type: DRUG
Intervention: Corticosteroids + Colchicine
Description: (≥ 20 mg prednisolone or its equivalent for ≥ 10 days) + Colchicine (1 mg/day for ≥ 10 days)
Study NCT05648734 — intervention group
Intervention type: DRUG
Intervention: Corticosteroids + Pirfenidone
Description: (≥ 20 mg prednisolone or its equivalent for ≥ 10 days) + Pirfenidone (267 mg TID for ≥ 14 days)
Study NCT05556499 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Biomarker assays
Description: Circulating bone biomarkers assays
Study NCT04917211 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Virtual reality mask
Description: The virtual reality mask is a mask with a screen that is put on the patient's face in the theatre before the surgery. It offers 3D scenarios of about 20 to 40 minutes on five different themes (the Zen garden, the mountain, the forest, the beach, the scuba diving) with music. The video-headset, equipped with head movement sensors, allows the 3D vision of a natural virtual world and the audio-headset emits sounds adapted to the virtual world and music therapy. The RV mask, via multi-sensorial immersion, focuses on two therapeutic targets which are pain and anxiety. It is a non-drug approach cousin to hypnosis. Its therapeutic effects are based on a distractive effect: attentive capture, an emotional effect: playfulness and positive suggestion, and a behavioral effect: the patient participates and is an actor in his care.~
Study NCT05344456 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Change in the device PVC algorithm to ''Off''
Description: PVC algorithm change from Atrial Pace mode to Off
Study NCT05627219 — intervention group
Intervention type: BEHAVIORAL
Intervention: Training and Education
Description: Undergo training and education
Study NCT05627219 — intervention group
Intervention type: OTHER
Intervention: Educational Intervention
Description: Receive educational booklet
Study NCT05627219 — intervention group
Intervention type: PROCEDURE
Intervention: Discussion
Description: Attend discussion with peer genetic coach
Study NCT04831281 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATH-1017
Description: Daily subcutaneous injection of ATH-1017 in a pre-filled syringe
Study NCT04831281 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily subcutaneous injection of Placebo in a pre-filled syringe
Study NCT05381064 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: artificial intelligence assistance system
Description: A deep learning-based bile duct scanning system that can prompt endoscopists to scan standard stations, identify bile ducts and stones in real time
Study NCT05096988 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: PKU sphere liquid
Description: PKU sphere liquid will be prescribed by the study dietitian based on the patient's individual requirements.
Study NCT06411795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: Given via epidural and injection
Study NCT06411795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydromorphone
Description: Given via epidural
Study NCT06411795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iopamidol
Description: Given via epidural
Study NCT06411795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal Bupivacaine
Description: Given injection
Study NCT06411795 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medical Chart Review
Description: Ancillary studies
Study NCT06411795 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06411795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thoracic Epidural Analgesia
Description: Undergo thoracic epidural placement
Study NCT06411795 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound Imaging
Description: Undergo ultrasound
Study NCT06411795 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: X-Ray Imaging
Description: Undergo x-ray
Study NCT06538883 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sedation with Ciprofol
Description: During the drug administration period, ciprofol were IV infused at loading doses of 0.1 mg/kg, respectively, over 4 minutes ± 30 seconds depending on the physical condition of each patient. Ciprofol were then immediately administered at an initial maintenance dose of 0.3 mg/kg/hr, with a target sedation depth of RASS +1 to -2, based on the Pain, Agitation/sedation, Delirium, Immobility (rehabilitation/mobilization), and Sleep (disruption) guideline.
Study NCT06538883 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sedation with Propofol
Description: During the drug administration period, propofol were IV infused at loading doses of 0.5 mg/kg, respectively, over 4 minutes ± 30 seconds depending on the physical condition of each patient. Propofol were then immediately administered at an initial maintenance dose of 1.5 mg/kg/hr, with a target sedation depth of RASS +1 to -2, based on the Pain, Agitation/sedation, Delirium, Immobility (rehabilitation/mobilization), and Sleep (disruption) guideline.
Study NCT05811403 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Epigallocatechin gallate (EGCG)
Description: Epigallocatechin gallate (EGCG) is a white powder that can be obtained from tea leaves. It accounts for 50-60 % of catechin content of tea polyphenols with a wide range of biological activities including antioxidant, antimicrobial, anti-inflammatory, immune regulatory, anti-tumour effects.
Study NCT05811403 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sodium hypochlorite (NaOCl)
Description: Sodium hypochlorite (NaOCl) is an excellent non-specific proteolytic and antimicrobial agent that provides disinfection of the dentin-pulp interface.
Study NCT05811403 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (NaOCl)
Description: Sodium hypochlorite (NaOCl) is an excellent non-specific proteolytic and antimicrobial agent that provides disinfection of the dentin-pulp interface.
Study NCT05811403 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate (MTA)
Description: Mineral trioxide aggregate (MTA) is the material of choice for pulp capping in vital pulp therapy.
Study NCT05811403 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mineral trioxide aggregate (MTA)
Description: Mineral trioxide aggregate (MTA) is the material of choice for pulp capping in vital pulp therapy.
Study NCT05811403 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Premixed bioceramic putty
Description: Bioceramic putty is a premixed, ready-to-use calcium silicate-based material which can be used as a pulp capping material.
Study NCT04195633 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Description: Given IV or PO
Study NCT04195633 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Filgrastim
Description: Given IV
Study NCT05129397 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mom Power
Description: Virtual Mom Power is a manualized multi-family group intervention consisting of 10 virtual group + 2 individual sessions led by two masters-level co-facilitators. Virtual groups are 90 minutes, following a structured format via secure HIPAA compatible video platform. The curriculum includes 5 core components: (1) Attachment-Focused Parenting Education; (2) Self-Care; (3) Parenting Practice (4) Social Support; \& (5) Connection to Resources. Individual sessions combine motivational interviewing with MP core components and focus on identifying goals and barriers. Weekly between-group phone/text check-ins are also a part of the curriculum, used to strengthen connection, build trust, ensure safety, and assess basic needs.
Study NCT05129397 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mom Power Informational Mailing
Description: This active comparison condition intervention includes two individual sessions along with 10 weeks of informational mailing with content related to Mom Power core concepts.
Study NCT04568668 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ActionADE
Description: ActionADE is a software application that allows healthcare providers to document standardized adverse drug event information in a user-friendly and standardized manner. We integrated ActionADE uni-directionally with PharmaNet, a secure province-wide network that links all pharmacies in British Columbia to a central data system. This allows care providers to pull in demographic information and visualize their patient's medication dispensing history.~In 2020, we enabled bi-directional integration with PharmaNet allowing clinicians to transmit standardized adverse drug event information back to the PharmaNet database. The three dominant community pharmacy systems in the geographic area of the trial will display the adverse drug event information in their systems, and generate patient-specific medication-level alerts when pharmacists attempt to re-dispense a culprit medication.
Study NCT04697407 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Blood sampling
Description: In all groups, 80 ml of blood will be collected. For patients, this will be done during routine cares.
Study NCT04697407 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood sampling
Description: In all groups, 80 ml of blood will be collected. For patients, this will be done during routine cares.
Study NCT04697407 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CSF sampling
Description: Only in both patients groups whom will have a CSF sampling in routine care, some CSF will be collected for the study in addition, with a limit of 5 ml for routine care and study.
Study NCT04697407 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: CSF sampling
Description: Only in both patients groups whom will have a CSF sampling in routine care, some CSF will be collected for the study in addition, with a limit of 5 ml for routine care and study.
Study NCT05730465 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Use of Omron Home Blood Pressure Cuff
Description: Use of an Omron Home Blood Pressure Cuff to monitor blood pressure after discharge
Study NCT05525117 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: covivio (additional to treatment as usual)
Description: Covivio is a dialogue-based online psychological intervention for patients with type 2 diabetes. This intervention includes elements that address disease literacy, physical activity and exercise, dieting and nutritional principles, coping with depression, etc. Content is adapted to users needs using interactive dialogues, illustrations and audio files. Participants may also continue with their usual treatment.
Study NCT05525117 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: treatment as usual
Description: Participants may continue with any treatment that they require (treatment as usual)
Study NCT05168358 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Overnight Bladder Drainage
Description: Parents or caregivers of the patients will be taught to place an indwelling catheter in the bladder at bedtime for about 8-12 h under a clean technique every night for one year. The catheter will then be allowed to drain freely into a gravity drainage collecting bag or in the diapers. On the next morning, the catheter will be removed and the timed voiding regimen will be resumed.
Study NCT04104438 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Basiliximab 20 MG
Description: Basiliximab induction followed by tacrolimus, corticosteroids and mycophenolic acid with a switch to everolimus by post operative day 30
Study NCT05280977 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: POST ISOMETRIC RELAXATION
Description: Group A (Post Isometric Relaxation + Conventional Physiotherapy): This group will receive Muscle Energy Technique in addition to conventional physiotherapy for the treatment of erector spinae tightness. The treatment will be given on alternate days for four weeks with 8 - 10 repetitions of METs per session.
Study NCT05280977 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: POST FACILITATION STRETCHING
Description: Group B (Post Facilitation Stretching + Conventional Physiotherapy):~This group will receive Post Facilitation Stretching Technique in addition to conventional physiotherapy for the treatment of erector spinae tightness. The treatment will be given on alternate days for four weeks with 8 - 10 repetitions of METs per session.
Study NCT05813197 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: My Choice - My Way!
Description: Support intervention for adolescents (15+) in out-of-home care (foster care, group home care, supported living, institutional care, etc). 16-19 sessions with a MCMW coach, 4-8 months, weekly to bi-weekly sessions.
Study NCT05813197 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual services
Description: Usual services
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Celecoxib
Description: preoperative pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celecoxib
Description: preoperative pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregabalin
Description: preoperative and discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin
Description: preoperative and discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tramadol
Description: preoperative pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: preoperative pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Intraoperative and discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Intraoperative and discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: Intraoperative and discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Description: Intraoperative and discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivicaine
Description: Intraoperative pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivicaine
Description: Intraoperative pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epinephrine
Description: Intraoperative pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine
Description: Intraoperative pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketorolac
Description: Intraoperative pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketorolac
Description: Intraoperative pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tizanidine
Description: Discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tizanidine
Description: Discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Magnesium
Description: Discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium
Description: Discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibuprofen
Description: Discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: Discharge pain medication given to all patients
Study NCT05488847 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxycodone Hydrochloride 5 Mg
Description: Only given to active comparator group
Study NCT05120310 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Calm App
Description: Participants will be asked to use the Calm app for at least 10 minutes per day for eight weeks. They will also be asked to schedule one live 20-minute coaching session with a Calm Coach within the first week of the eight-week intervention to help identify areas for health behavior improvements (i.e., Calm Concierge). Participants will be asked to download the Calm app to their mobile phone. The Calm Coaching for sleep program is administered by Calm for six weeks. Participants are asked to complete weekly modules and interact with a coach to help them improve their sleep. Participants also complete a sleep diary throughout the program.
Study NCT05120310 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: The Calm App
Description: Participants will be asked to use the Calm app for at least 10 minutes per day for eight weeks. They will also be asked to schedule one live 20-minute coaching session with a Calm Coach within the first week of the eight-week intervention to help identify areas for health behavior improvements (i.e., Calm Concierge). Participants will be asked to download the Calm app to their mobile phone. The Calm Coaching for sleep program is administered by Calm for six weeks. Participants are asked to complete weekly modules and interact with a coach to help them improve their sleep. Participants also complete a sleep diary throughout the program.
Study NCT04195633 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV
Study NCT05979571 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile health app
Description: Breastfeeding knowledge and promotion information will be delivered through the AmiBreastfeed app platform